Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways

European Journal of Immunology - Tập 27 Số 3 - Trang 660-665 - 1997
Jacqueline Samaridis1, Marco Colonna2
1Basel Institute for Immunology, Switzerland
2Basel Institute for Immunology, Basel, Switzerland

Tóm tắt

AbstractWe have identified two novel human cDNA encoding transmembrane proteins of the immunoglobulin superfamily (IgSF). The two cDNA, called immunoglobulin‐like transcripts 1 and 2 (ILT1 and ILT2), are expressed in myeloid and lymphoid cells and are homologous to bovine Fcγ2R, human killer cell inhibitory receptors (KIR), human FcαR, and mouse gp49. Furthermore, ILT1 and ILT2 are encoded on chromosome 19, as are FcαR and KIR. While the ILT1 and ILT2 extracellular domains are homologous, the transmembrane and cytoplasmic domains differ substantially. ILT1 has an arginine within the transmembrane region, followed by a short cytoplasmic tail, similar to human FcαRI and bovine Fcγ2R. ILT2 has a long cytoplasmic tail, which contains two YxxV and two YxxL pairs similar to the immunoreceptor tyrosine‐based inhibitory motifs in KIR that are known to bind the phosphotyrosine phosphatase SHP‐1. These cytoplasmic features suggest that ILT1 and ILT2 may mediate novel transmembrane signals by which myeloid and lymphoid cell responses can be either activated or inhibited.

Từ khóa


Tài liệu tham khảo

10.1146/annurev.iy.12.040194.002325

10.1016/0092-8674(94)90334-4

10.4049/jimmunol.147.8.2652

10.1002/j.1460-2075.1992.tb05340.x

Daeron M., 1994, J. Immunol., 152, 783, 10.4049/jimmunol.152.2.783

10.1084/jem.181.6.1953

10.1126/science.1535455

10.1038/368070a0

10.1126/science.7618087

10.1126/science.7716523

10.1038/383263a0

Daeron M., 1995, Immunity, 3, 635, 10.1016/1074-7613(95)90134-5

10.1126/science.7716543

10.1016/1074-7613(95)90025-X

D'Andrea A., 1995, J. Immunol., 155, 2306, 10.4049/jimmunol.155.5.2306

10.1016/S1074-7613(00)80300-3

10.1084/jem.184.1.93

Olcese L., 1996, J. Immunol., 156, 4531, 10.4049/jimmunol.156.12.4531

10.1084/jem.184.1.295

10.1084/jem.182.3.875

Zhang G., 1995, J. Immunol., 155, 1534, 10.4049/jimmunol.155.3.1534

10.1084/jem.172.6.1665

Arm J. P., 1991, J. Biol. Chem., 266, 15966, 10.1016/S0021-9258(18)98502-9

10.1146/annurev.iy.06.040188.002121

10.1016/B978-0-12-372180-8.50009-3

10.1073/pnas.85.23.8998

10.1016/0161-5890(89)90140-5

Lund J., 1991, J. Immunol., 147, 2657, 10.4049/jimmunol.147.8.2657

10.1084/jem.183.4.1579

10.1016/S0065-2776(08)60629-X

10.1126/science.7624800

10.1073/pnas.91.14.6259

10.4049/jimmunol.153.7.3228

10.1073/pnas.93.20.10809

10.1016/0092-8674(92)90636-Q

10.1083/jcb.117.2.311

10.1146/annurev.iy.09.040191.002325